首页|柯萨奇病毒A组10型VP1蛋白线性中和表位的筛选和鉴定

柯萨奇病毒A组10型VP1蛋白线性中和表位的筛选和鉴定

扫码查看
柯萨奇病毒A组10型(CV-A10)是引起手足口病(HFMD)的常见病原体之一.应用重叠肽法筛选出覆盖CV-A10全长 VP1区氨基酸序列的39条候选表位肽段,以间接酶联免疫吸附试验(ELISA)及微量中和抑制试验验证.结果发现,候选表位P6(CV-A10 VP1区第39~53位氨基酸)与CV-A10全病毒抗血清具有高反应性,且在3.91 μg/mL的稀释质量浓度时仍具有中和抑制作用,为潜在中和表位.用P6肽免疫小鼠制备相应的抗血清,并以微量中和试验验证其保护能力,结果显示,P6抗血清的几何平均中和效价为1:8.97,可确定P6为CV-A10的中和表位.为了解P6序列在CV-A10型内的保守性,将P6的氨基酸序列与CV-A10各基因型代表株进行比对分析,结果显示,P6在CV-A10型内高度保守,表明P6为CV-A10的广谱性中和表位,可应用于CV-A10表位疫苗的研发.本研究旨在筛选鉴定CV-A10 VP1蛋白上的线性中和表位,为CV-A10表位疫苗的研发和HFMD的防控奠定基础.
Screening and Identification of Linear Epitopes on the VP1 Protein of Coxsackievirus A10
Coxsackievirus A10(CV-A10)is one of the most common pathogens causing hand,foot and mouth disease(HFMD).The 39 candidate epitope peptides covering the amino acid sequence of the VP1 region of CV-A10 were screened by using the overlapping peptide method and verified by indirect enzyme linked immunosorbent assay(ELISA)and microneutral-ization inhibition assays.It has been found that candidate epitope P6(amino acid 39~53 in VP1 region of CV-A10)showed high reactivity with CV-A10 virus serum,and still showed neutralizing inhibition effect at 3.91 μg/mL dilution mass concentration,which was a potential neutralizing epitope.P6 antiserum was prepared by immunizing mice with P6 peptide,and microneutral-ization test was used to verify its protective effect.The results showed a 1:8.97 geometric mean neutralizing titer for P6 antise-rum,which identified P6 as the neutralizing epitope of CV-A10.In order to understand the conservativeness of P6 sequence in CV-A10,the amino acid sequence of the P6 was compared with the representative strains of CV-A10 genotype,and the results showed that P6 was highly conserved in CV-A10.It indicated that P6 is a conserved linear neutralization epitope of CV-A10,which has the potential to resist the infection of various genotypes of CV-A10,and can be used as a target for the development of CV-A10 epitope vaccine.This study aimed to screen and identify linearly neutralizing epitopes on the CV-A10 VP1 protein and to lay a foundation for the development of CV-A10 epitope vaccine and HFMD prevention.

coxsackievirus A10VP1 proteinlinear neutral epitopevaccinehand,foot and mouth disease

甘燕媚、何韵怡、瞿颖、吴岳、刘启亮、刘洪波

展开 >

桂林医学院第二附属医院检验科,桂林 541199

桂林医学院医学检验学院,桂林 541199

桂林医学院智能医学与生物技术学院,桂林 541199

柯萨奇病毒A组10型 VP1蛋白 线性中和表位 疫苗 手足口病

国家自然科学基金

81660280

2024

激光生物学报
中国遗传学会

激光生物学报

CSTPCD
影响因子:0.378
ISSN:1007-7146
年,卷(期):2024.33(2)
  • 33